JNJ-64619178
CAS: 2086772-26-9
Ref. 3D-LID77226
| 1mg | 260.00 € | ||
| 2mg | 381.00 € | ||
| 5mg | 542.00 € | ||
| 10mg | 775.00 € | ||
| 25mg | 1,154.00 € |
Product Information
JNJ-64619178 is a novel small molecule that targets the methyltransferase domain of the protein PRMT5. The compound has been shown to induce apoptosis in cancer cells, and is currently being evaluated for safety and efficacy in clinical trials. This drug has been shown to have a favorable safety profile and shows no adverse effects on erythropoiesis. JNJ-64619178 is an investigational drug that belongs to the class of compounds that bind to the target site on PRMT5, which is involved in regulating gene expression. It binds to enzymes with methyltransferase activity and inhibits RNA splicing, leading to cell death by apoptosis.
Chemical properties
Technical inquiry about: 3D-LID77226 JNJ-64619178
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
